Folate-Cyclodextrin Conjugate for Targeted Chemotherapy

March 2021 in “ Arrow - TU Dublin (Technological University Dublin) ”

Zlata Tofzikovskaya, Orla Howe, Mary McNamara, Christine O’Connor

Studysummary This study tested a folate-conjugate drug delivery system and found its cytotoxicity depends on whether the treated cells overexpress folate receptors, suggesting potential for targeted chemotherapy.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on arrow.dit.ie →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Drug Targeting to the Hair Follicles: A Cyclodextrin-Based Drug Delivery

32 citations , March 2009 in “AAPS PharmSciTech”

research Comparison of Efficacy and Specificity in Cancer‐Targeting Prodrug Conjugates

1 citations , May 2022 in “The FASEB journal”

This article discusses the development of targeted prodrug conjugates aimed at selectively attacking cancer cells while avoiding healthy ones, but reports no experimental results yet.

research Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations

20 citations , May 2023 in “Cancer Nanotechnology”

The researchers reported that their novel formulation of pterostilbene-loaded ethoniosomes with folic acid coating effectively targeted lung cancer cells in vitro and demonstrated promising results in animal models, indicating potential for future targeted chemotherapy applications.

Fabrication and In Vitro Evaluation of Silk Fibroin-Folic Acid Decorated Paclitaxel and Hydroxyurea Nanostructured Lipid Carriers for Targeting Ovarian Cancer Cells: A Double Sword Approach

research Fabrication and in vitro evaluation of silk fibroin-folic acid decorated paclitaxel and hydroxyurea nanostructured lipid carriers for targeting ovarian cancer cells: A double sword approach

3 citations , February 2023 in “Journal of drug delivery science and technology”

In vitro, this study found that PTX and HU SF-FA NLCs showed greater cytotoxicity and apoptosis in ovarian cancer cells than pure paclitaxel, suggesting promise as a targeted drug delivery platform.

research An in-depth study of DOPE:DOPC liposomes to maximize targeted drug delivery to cancer-associated cells

January 2023

This research found that liposome drug delivery systems, particularly with targeted modifications, show promise for improving effectiveness and reducing toxicity in combination cancer therapies.